Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 117
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Genes Dev ; 25(19): 2031-40, 2011 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-21979916

RESUMEN

DNA-dependent protein kinase (DNA-PK) is a central regulator of DNA double-strand break (DSB) repair; however, the identity of relevant DNA-PK substrates has remained elusive. NR4A nuclear orphan receptors function as sequence-specific DNA-binding transcription factors that participate in adaptive and stress-related cell responses. We show here that NR4A proteins interact with the DNA-PK catalytic subunit and, upon exposure to DNA damage, translocate to DSB foci by a mechanism requiring the activity of poly(ADP-ribose) polymerase-1 (PARP-1). At DNA repair foci, NR4A is phosphorylated by DNA-PK and promotes DSB repair. Notably, NR4A transcriptional activity is entirely dispensable in this function, and core components of the DNA repair machinery are not transcriptionally regulated by NR4A. Instead, NR4A functions directly at DNA repair sites by a process that requires phosphorylation by DNA-PK. Furthermore, a severe combined immunodeficiency (SCID)-causing mutation in the human gene encoding the DNA-PK catalytic subunit impairs the interaction and phosphorylation of NR4A at DSBs. Thus, NR4As represent an entirely novel component of DNA damage response and are substrates of DNA-PK in the process of DSB repair.


Asunto(s)
Proteínas de Unión al Calcio/metabolismo , Roturas del ADN de Doble Cadena , Reparación del ADN , Proteína Quinasa Activada por ADN/metabolismo , Proteínas de Unión al ADN/metabolismo , Proteínas Nucleares/metabolismo , Miembro 2 del Grupo A de la Subfamilia 4 de Receptores Nucleares/metabolismo , Animales , Línea Celular , Células Cultivadas , Técnicas de Inactivación de Genes , Humanos , Ratones , Miembro 2 del Grupo A de la Subfamilia 4 de Receptores Nucleares/genética , Fosforilación , Transporte de Proteínas , Inmunodeficiencia Combinada Grave/genética , Inmunodeficiencia Combinada Grave/fisiopatología
2.
Mol Cell ; 40(4): 521-32, 2010 Nov 24.
Artículo en Inglés | MEDLINE | ID: mdl-21095583

RESUMEN

The versatile cytokine transforming growth factor ß (TGF-ß) regulates cellular growth, differentiation, and migration during embryonic development and adult tissue homeostasis. Activation of TGF-ß receptors leads to phosphorylation of Smad2 and Smad3, which oligomerize with Smad4 and accumulate in the nucleus where they recognize gene regulatory regions and orchestrate transcription. Termination of Smad-activated transcription involves Smad dephosphorylation, nuclear export, or ubiquitin-mediated degradation. In an unbiased proteomic screen, we identified poly(ADP-ribose) polymerase-1 (PARP-1) as a Smad-interacting partner. PARP-1 dissociates Smad complexes from DNA by ADP-ribosylating Smad3 and Smad4, which attenuates Smad-specific gene responses and TGF-ß-induced epithelial-mesenchymal transition. Thus, our results identify ADP-ribosylation of Smad proteins by PARP-1 as a key step in controlling the strength and duration of Smad-mediated transcription.


Asunto(s)
Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteínas Smad/metabolismo , Transcripción Genética , Factores de Ribosilacion-ADP/metabolismo , Línea Celular , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , ADN/metabolismo , Transición Epitelial-Mesenquimal/efectos de los fármacos , Humanos , Complejos Multiproteicos/metabolismo , Poli(ADP-Ribosa) Polimerasa-1 , Regiones Promotoras Genéticas/genética , Unión Proteica/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Especificidad por Sustrato/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología
3.
J Biol Chem ; 288(1): 343-54, 2013 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-23161541

RESUMEN

The multifunctional protein nucleolin (NCL) is overexpressed on the surface of activated endothelial and tumor cells and mediates the stimulatory actions of several angiogenic growth factors, such as pleiotrophin (PTN). Because α(v)ß(3) integrin is also required for PTN-induced cell migration, the aim of the present work was to study the interplay between NCL and α(v)ß(3) by using biochemical, immunofluorescence, and proximity ligation assays in cells with genetically altered expression of the studied molecules. Interestingly, cell surface NCL localization was detected only in cells expressing α(v)ß(3) and depended on the phosphorylation of ß(3) at Tyr(773) through receptor protein-tyrosine phosphatase ß/ζ (RPTPß/ζ) and c-Src activation. Downstream of α(v)ß(3,) PI3K activity mediated this phenomenon and cell surface NCL was found to interact with both α(v)ß(3) and RPTPß/ζ. Positive correlation of cell surface NCL and α(v)ß(3) expression was also observed in human glioblastoma tissue arrays, and inhibition of cell migration by cell surface NCL antagonists was observed only in cells expressing α(v)ß(3). Collectively, these data suggest that both expression and ß(3) integrin phosphorylation at Tyr(773) determine the cell surface localization of NCL downstream of the RPTPß/ζ/c-Src signaling cascade and can be used as a biomarker for the use of cell surface NCL antagonists as anticancer agents.


Asunto(s)
Movimiento Celular , Células Endoteliales/citología , Regulación Neoplásica de la Expresión Génica , Glioma/metabolismo , Fosfoproteínas/metabolismo , Proteínas de Unión al ARN/metabolismo , Animales , Antineoplásicos/farmacología , Biomarcadores/metabolismo , Células CHO , Proteínas Portadoras/metabolismo , Membrana Celular/metabolismo , Cricetinae , Citocinas/metabolismo , Humanos , Integrina alfaVbeta3/metabolismo , Microscopía Fluorescente/métodos , Neovascularización Patológica , Fosforilación , Ratas , Transducción de Señal , Nucleolina
4.
Chembiochem ; 15(13): 1873-6, 2014 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-25044410

RESUMEN

Matrix metalloproteinase 2 (MMP-2) is involved in cancer development and is overexpressed in a variety of malignant tumors. MMP-2 activity is controlled mainly by transcription, proteolytic activation, and inhibition by endogenous inhibitors. It had previously been demonstrated that MMP-2 activity is also regulated by phosphorylation at several sites by protein kinase C. Here we demonstrate, by means of bioinformatics and biochemical and cellular assays, that protein kinase CK2 also acts as a modulator of MMP-2 activity. CK2 down-regulates MMP-2 in vitro, and inhibition of CK2 in human fibrosarcoma cells results in up-regulation of MMP-2. The discovery of the crosstalk between MMP-2 and CK2 opens the possibility of new combined anticancer therapies.


Asunto(s)
Quinasa de la Caseína II/metabolismo , Quinasa de la Caseína II/farmacología , Metaloproteinasa 2 de la Matriz/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Línea Celular Tumoral , Biología Computacional , Regulación hacia Abajo/efectos de los fármacos , Fibrosarcoma/metabolismo , Humanos , Fosforilación , Receptor Cross-Talk/efectos de los fármacos
5.
J Biol Chem ; 287(9): 6307-17, 2012 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-22203676

RESUMEN

Reduction of hydroxylamines and amidoximes is important for drug activation and detoxification of aromatic and heterocyclic amines. Such a reductase system was previously found to be of high activity in adipose tissue and liver, and furthermore, in vitro studies using recombinant truncated and purified enzymes suggested the participation of cytochrome b(5) reductase (CYB5R), cytochrome b(5) (CYB5), and molybdenum cofactor sulfurase C-terminal containing 1 and 2 (MOSC1 and -2). Here, we show that purified rat liver outer mitochondrial membrane contains high amidoxime reductase activity and that MOSC2 is exclusively localized to these membranes. Moreover, using the same membrane fraction, we could show direct binding of a radiolabeled benzamidoxime substrate to MOSC2. Following differentiation of murine 3T3-L1 cells into mature adipocytes, the MOSC2 levels as well as the amidoxime reductase activity were increased, indicating that the enzyme is highly regulated under lipogenic conditions. siRNA-mediated down-regulation of MOSC2 and the mitochondrial form of cytochrome b(5) type B (CYB5B) significantly inhibited the reductase activity in the differentiated adipocytes, whereas down-regulation of MOSC1, cytochrome b(5) type A (CYB5A), CYB5R1, CYB5R2, or CYB5R3 had no effect. Down-regulation of MOSC2 caused impaired lipid synthesis. These results demonstrate for the first time the direct involvement of MOSC2 and CYB5B in the amidoxime reductase activity in an intact cell system. We postulate the presence of a novel reductive enzyme system of importance for lipid synthesis that is exclusively localized to the outer mitochondrial membrane and is composed of CYB5B, MOSC2, and a third unknown component (a CYB5B reductase).


Asunto(s)
Adipocitos/metabolismo , Proteínas Portadoras/metabolismo , Citocromos b5/metabolismo , Hemoproteínas/metabolismo , Lípidos/biosíntesis , Mitocondrias Hepáticas/enzimología , Proteínas Mitocondriales/metabolismo , Oxidorreductasas/metabolismo , Células 3T3-L1 , Adipocitos/citología , Adipogénesis/fisiología , Animales , Diferenciación Celular/fisiología , Fraccionamiento Celular , Citocromos b5/genética , Femenino , Proteínas de Unión al Hemo , Inactivación Metabólica/fisiología , Ratones , Membranas Mitocondriales/enzimología , Proteínas Mitocondriales/genética , Oxidorreductasas/genética , ARN Interferente Pequeño/farmacología , Ratas , Xenobióticos
6.
Biochim Biophys Acta ; 1824(12): 1334-41, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22850197

RESUMEN

The role of filamin in molluscan catch muscles is unknown. In this work three proteins isolated from the posterior adductor muscle of the sea mussel Mytilus galloprovincialis were identified by MALDI-TOF/TOF MS as homologous to mammalian filamin. They were named FLN-270, FLN-230 and FLN-105, according to their apparent molecular weight determined by SDS-PAGE: 270kDa, 230kDa and 105kDa, respectively. Both FLN-270 and FLN-230 contain the C-terminal dimerization domain and the N-terminal actin-binding domain typical of filamins. These findings, together with the data from peptide mass fingerprints, indicate that FLN-270 and FLN-230 are different isoforms of mussel filamin, with FLN-230 being the predominant isoform in the mussel catch muscle. De novo sequencing data revealed structural differences between both filamin isoforms at the rod 2 segment, the one responsible for the interaction of filamin with the most of its binding partners. FLN270 but not FLN230 was phosphorylated in vitro by cAMP-dependent protein kinase. As for the FLN-105, it would be an N-terminal proteolytic fragment generated from the FLN-270 isoform or a C-terminally truncated variant of filamin. On the other hand, a 45-kDa protein that copurifies with mussel catch muscle filamins was identified as the mussel calponin-like protein. The fact that this protein coelutes with the FLN-270 isoform from a gel filtration chromatography suggests a specific interaction between both proteins.


Asunto(s)
Proteínas Contráctiles/análisis , Proteínas de Microfilamentos/análisis , Músculo Liso/química , Mytilus/química , Actinas/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Contráctiles/química , Filaminas , Proteínas de Microfilamentos/química , Datos de Secuencia Molecular , Peso Molecular , Isoformas de Proteínas , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
7.
Cell Mol Life Sci ; 69(2): 325-33, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21739232

RESUMEN

DNA aneuploidy has been identified as a prognostic factor in the majority of epithelial malignancies. We aimed at identifying ploidy-associated protein expression in endometrial cancer of different prognostic subgroups. Comparison of gel electrophoresis-based protein expression patterns between normal endometrium (n = 5), diploid (n = 7), and aneuploid (n = 7) endometrial carcinoma detected 121 ploidy-associated protein forms, 42 differentially expressed between normal endometrium and diploid endometrioid carcinomas, 37 between diploid and aneuploid endometrioid carcinomas, and 41 between diploid endometrioid and aneuploid uterine papillary serous cancer. Proteins were identified by mass spectrometry and evaluated by Ingenuity Pathway Analysis. Targets were confirmed by liquid chromatography/mass spectrometry. Mass spectrometry identified 41 distinct polypeptides and pathway analysis resulted in high-ranked networks with vimentin and Nf-κB as central nodes. These results identify ploidy-associated protein expression differences that overrule histopathology-associated expression differences and emphasize particular protein networks in genomic stability of endometrial cancer.


Asunto(s)
Carcinoma Endometrioide/genética , Cistadenocarcinoma Seroso/genética , Neoplasias Endometriales/genética , Inestabilidad Genómica , Anciano , Anciano de 80 o más Años , Aneuploidia , Carcinoma Endometrioide/metabolismo , Carcinoma Endometrioide/patología , Cistadenocarcinoma Seroso/metabolismo , Cistadenocarcinoma Seroso/patología , Neoplasias Endometriales/metabolismo , Neoplasias Endometriales/patología , Endometrio/metabolismo , Endometrio/patología , Femenino , Humanos , Persona de Mediana Edad , FN-kappa B/metabolismo , Análisis por Matrices de Proteínas , Proteómica , Vimentina/metabolismo
8.
Eukaryot Cell ; 11(7): 864-73, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22611020

RESUMEN

In recent years, proteomics has come of age with the development of efficient tools for purification, identification, and characterization of gene products predicted by genome projects. The intestinal protozoan Giardia intestinalis can be transfected, but there is only a limited set of vectors available, and most of them are not user friendly. This work delineates the construction of a suite of cassette-based expression vectors for use in Giardia. Expression is provided by the strong constitutive ornithine carbamoyltransferase (OCT) promoter, and tagging is possible in both N- and C-terminal configurations. Taken together, the vectors are capable of providing protein localization and production of recombinant proteins, followed by efficient purification by a novel affinity tag combination, streptavidin binding peptide-glutathione S-transferase (SBP-GST). The option of removing the tags from purified proteins was provided by the inclusion of a PreScission protease site. The efficiency and feasibility of producing and purifying endogenous recombinant Giardia proteins with the developed vectors was demonstrated by the purification of active recombinant arginine deiminase (ADI) and OCT from stably transfected trophozoites. Moreover, we describe the tagging, purification by StrepTactin affinity chromatography, and compositional analysis by mass spectrometry of the G. intestinalis 26S proteasome by employing the Strep II-FLAG-tandem affinity purification (SF-TAP) tag. This is the first report of efficient production and purification of recombinant proteins in and from Giardia, which will allow the study of specific parasite proteins and protein complexes.


Asunto(s)
Giardia/enzimología , Giardiasis/parasitología , Plásmidos/genética , Complejo de la Endopetidasa Proteasomal/aislamiento & purificación , Proteínas Protozoarias/aislamiento & purificación , Factores de Virulencia/aislamiento & purificación , Expresión Génica , Vectores Genéticos/genética , Vectores Genéticos/metabolismo , Giardia/química , Giardia/genética , Humanos , Hidrolasas/genética , Hidrolasas/metabolismo , Datos de Secuencia Molecular , Ornitina Carbamoiltransferasa/genética , Ornitina Carbamoiltransferasa/metabolismo , Plásmidos/metabolismo , Complejo de la Endopetidasa Proteasomal/genética , Complejo de la Endopetidasa Proteasomal/metabolismo , Proteómica , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Factores de Virulencia/genética , Factores de Virulencia/metabolismo
9.
J Biol Chem ; 286(19): 16871-8, 2011 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-21454564

RESUMEN

We propose Cys-X scanning as a semisynthetic approach to engineer the functional properties of recombinant proteins. As in the case of Ala scanning, key residues in the primary structure are identified, and one of them is replaced by Cys via site-directed mutagenesis. The thiol of the residue introduced is subsequently modified by alternative chemical reagents to yield diverse Cys-X mutants of the protein. This chemical approach is orthogonal to Ala or Cys scanning and allows the expansion of the repertoire of amino acid side chains far beyond those present in natural proteins. In its present application, we have introduced Cys-X residues in human glutathione transferase (GST) M2-2, replacing Met-212 in the substrate-binding site. To achieve selectivity of the modifications, the Cys residues in the wild-type enzyme were replaced by Ala. A suite of simple substitutions resulted in a set of homologous Met derivatives ranging from normethionine to S-heptyl-cysteine. The chemical modifications were validated by HPLC and mass spectrometry. The derivatized mutant enzymes were assayed with alternative GST substrates representing diverse chemical reactions: aromatic substitution, epoxide opening, transnitrosylation, and addition to an ortho-quinone. The Cys substitutions had different effects on the alternative substrates and differentially enhanced or suppressed catalytic activities depending on both the Cys-X substitution and the substrate assayed. As a consequence, the enzyme specificity profile could be changed among the alternative substrates. The procedure lends itself to large-scale production of Cys-X modified protein variants.


Asunto(s)
Cisteína/química , Glutatión Transferasa/genética , Alanina/química , Sitios de Unión , Catálisis , Dominio Catalítico , Cromatografía Líquida de Alta Presión/métodos , Clonación Molecular , Glutatión/química , Glutatión Transferasa/química , Glutatión Transferasa/metabolismo , Humanos , Espectrometría de Masas/métodos , Metionina/química , Mutagénesis Sitio-Dirigida , Unión Proteica , Especificidad por Sustrato
10.
EMBO J ; 27(22): 2955-65, 2008 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-18923419

RESUMEN

Transforming growth factor (TGF)-beta induces various cellular responses principally through Smad-dependent transcriptional regulation. Activated Smad complexes cooperate with transcription factors in regulating a group of target genes. The target genes controlled by the same Smad-cofactor complexes are denoted a synexpression group. We found that an Id-like helix-loop-helix protein, human homologue of Maid (HHM), is a synexpression group-restricted regulator of TGF-beta signalling. HHM suppressed TGF-beta-induced growth inhibition and cell migration but not epithelial-mesenchymal transition. In addition, HHM inhibited TGF-beta-induced expression of plasminogen activator inhibitor-type 1 (PAI-1), PDGF-B, and p21(WAF), but not Snail. We identified a basic-helix-loop-helix protein, Olig1, as one of the Smad-binding transcription factors affected by HHM. Olig1 interacted with Smad2/3 in response to TGF-beta stimulation, and was involved in transcriptional activation of PAI-1 and PDGF-B. HHM, but not Id proteins, inhibited TGF-beta signalling-dependent association of Olig1 with Smad2/3 through physical interaction with Olig1. HHM thus appears to regulate a subset of TGF-beta target genes including the Olig1-Smad synexpression group. HHM is the first example of a cellular response-selective regulator of TGF-beta signalling with clearly determined mechanisms.


Asunto(s)
Transducción de Señal/fisiología , Factores de Transcripción/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Animales , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/metabolismo , Línea Celular , Regulación de la Expresión Génica , Glioma/metabolismo , Glioma/patología , Humanos , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Inhibidor 1 de Activador Plasminogénico/genética , Inhibidor 1 de Activador Plasminogénico/metabolismo , Regiones Promotoras Genéticas , Unión Proteica , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas c-sis/metabolismo , Interferencia de ARN , Proteínas Smad/genética , Proteínas Smad/metabolismo , Factores de Transcripción/genética , Transcripción Genética , Factor de Crecimiento Transformador beta/genética
11.
Cell Mol Life Sci ; 68(19): 3261-74, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21290163

RESUMEN

DNA aneuploidy has been identified as a prognostic factor for epithelial malignancies. Further understanding of the translation of DNA aneuploidy into protein expression will help to define novel biomarkers to improve therapies and prognosis. DNA ploidy was assessed by image cytometry. Comparison of gel-electrophoresis-based protein expression patterns of three diploid and four aneuploid colorectal cancer cell lines detected 64 ploidy-associated proteins. Proteins were identified by mass spectrometry and subjected to Ingenuity Pathway Analysis resulting in two overlapping high-ranked networks maintaining Cellular Assembly and Organization, Cell Cycle, and Cellular Growth and Proliferation. CAPZA1, TXNL1, and HDAC2 were significantly validated by Western blotting in cell lines and the latter two showed expression differences also in clinical samples using a tissue microarray of normal mucosa (n=19), diploid (n=31), and aneuploid (n=47) carcinomas. The results suggest that distinct protein expression patterns, affecting TXNL1 and HDAC2, distinguish aneuploid with poor prognosis from diploid colorectal cancers.


Asunto(s)
Aneuploidia , Carcinoma/genética , Neoplasias Colorrectales/genética , Diploidia , Histona Desacetilasa 2/genética , Tiorredoxinas/genética , Western Blotting , Proteína CapZ/genética , Proteína CapZ/metabolismo , Proteína CapZ/fisiología , Carcinoma/diagnóstico , Carcinoma/patología , Línea Celular Tumoral , Estudios de Cohortes , Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/patología , ADN de Neoplasias/química , Inestabilidad Genómica , Histona Desacetilasa 2/metabolismo , Histona Desacetilasa 2/fisiología , Humanos , Pronóstico , Tiorredoxinas/metabolismo , Tiorredoxinas/fisiología
12.
Proc Natl Acad Sci U S A ; 106(29): 11966-71, 2009 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-19570996

RESUMEN

Deletion or mutation of the SAP gene is associated with the X-linked lymphoproliferative disease (XLP) that is characterized by extreme sensitivity to Epstein-Barr virus (EBV). Primary infection of the affected individuals leads to serious, sometimes fatal infectious mononucleosis (IM) and proneness to lymphoma. Our present results revealed a proapoptotic function of SAP by which it contributes to the maintenance of T-cell homeostasis and to the elimination of potentially dangerous DNA-damaged cells. Therefore, the loss of this function could be responsible for the uncontrolled T-cell proliferation in fatal IM and for the generation of lymphomas. We show now the role of SAP in apoptosis in T and B lymphocyte-derived lines. Among the clones of T-ALL line, the ones with higher SAP levels succumbed more promptly to activation induced cell death (AICD). Importantly, introduction of SAP expression into lymphoblastoid cell lines (LCL) established from XLP patients led to elevated apoptotic response to DNA damage. Similar results were obtained in the osteosarcoma line, Saos-2. We have shown that the anti-apoptotic protein VCP (valosin-containing protein) binds to SAP, suggesting that it could be instrumental in the enhanced apoptotic response modulated by SAP.


Asunto(s)
Apoptosis , Genes Ligados a X , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Trastornos Linfoproliferativos/metabolismo , Trastornos Linfoproliferativos/patología , Adenosina Trifosfatasas/metabolismo , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Biomarcadores/metabolismo , Proteínas de Ciclo Celular/metabolismo , Línea Celular Tumoral , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Membrana Celular/efectos de la radiación , Proliferación Celular/efectos de los fármacos , Proliferación Celular/efectos de la radiación , Células Clonales , Daño del ADN , Fase G2/efectos de los fármacos , Fase G2/efectos de la radiación , Rayos gamma , Humanos , Activación de Linfocitos/efectos de los fármacos , Activación de Linfocitos/efectos de la radiación , Mitosis/efectos de los fármacos , Mitosis/efectos de la radiación , Fitohemaglutininas/farmacología , Unión Proteica/efectos de los fármacos , Unión Proteica/efectos de la radiación , Retroviridae , Proteína Asociada a la Molécula de Señalización de la Activación Linfocitaria , Linfocitos T/citología , Linfocitos T/efectos de los fármacos , Transducción Genética , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/efectos de la radiación , Proteína que Contiene Valosina , Proteína bcl-X/metabolismo
13.
J Biol Chem ; 285(31): 23647-54, 2010 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-20507985

RESUMEN

Hyaluronan is a component of the extracellular matrix, which affects tissue homeostasis. In this study, we investigated the regulatory mechanisms of one of the hyaluronan-synthesizing enzymes, HAS2. Ectopic expression of Flag- and 6myc-HAS2 in COS-1 cells followed by immunoprecipitation and immunoblotting revealed homodimers; after co-transfection with Flag-HAS3, also heterodimers were seen. Furthermore, the expressed HAS2 was ubiquitinated. We identified one acceptor site for ubiquitin on lysine residue 190. Mutation of this residue led to inactivation of the enzymatic activity of HAS2. Interestingly, K190R-mutated HAS2 formed dimers with wt HAS2 and quenched the activity of wt HAS2, thus demonstrating a functional role of the dimeric configuration.


Asunto(s)
Regulación Enzimológica de la Expresión Génica , Glucuronosiltransferasa/química , Glucuronosiltransferasa/metabolismo , Ubiquitina/química , Animales , Sitios de Unión , Células COS , Catálisis , Línea Celular Transformada , Chlorocebus aethiops , Dimerización , Hialuronano Sintasas , Ratones , Modelos Biológicos , Mutagénesis Sitio-Dirigida , Mutación , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
14.
J Cell Biochem ; 112(1): 189-99, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21117064

RESUMEN

Echinococcus granulosus, the agent of hydatid disease, presents an indirect life cycle, with canines (mainly dogs) as definitive hosts, and herbivores and human as intermediary ones. In intermediary hosts fertile and infertile cysts develop, but only the first ones develop protoscoleces, the parasite form infective to definitive hosts. We report the presence of bovine IgGs in the germinal layer from infertile cysts (GLIC), in an order of magnitude greater than in the germinal layer from fertile cysts (GLFC). When extracted with salt solutions, bovine IgGs from GLIC are associated with low or with high affinity (most likely corresponding to non specific and antigen specific antibodies, respectively). Specific IgGs penetrate both the cells of the germinal layer and HeLa cultured cells and recognize parasitic proteins. These results, taken together with previous ones from our laboratory, showing induction of apoptosis in the germinal layer of infertile hydatid cysts, provide the first coherent explanation of the infertility process. They also offer the possibility of identifying the parasite antigens recognized, as possible targets for immune modulation.


Asunto(s)
Enfermedades de los Bovinos/inmunología , Equinococosis/veterinaria , Echinococcus granulosus/inmunología , Infertilidad/veterinaria , Animales , Bovinos , Enfermedades de los Bovinos/metabolismo , Enfermedades de los Bovinos/patología , Equinococosis/inmunología , Equinococosis/metabolismo , Echinococcus granulosus/metabolismo , Células HeLa , Humanos , Inmunidad Humoral , Infertilidad/inmunología , Microscopía Fluorescente
15.
BMC Microbiol ; 11: 233, 2011 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-22011206

RESUMEN

BACKGROUND: To date, eight assemblages of Giardia lamblia have been described, but only assemblages A and B are known to infect humans. Despite the fact that the genomic, biological, and clinical differences found between these two assemblages has raised the possibility that they may be considered different species, there is relatively limited information on their phenotypic differences. In the present study, we developed monoclonal antibodies against alpha-1 and beta giardin, two immunodominant proteins produced during G. lamblia infection, and studied their expression and localization in WB (assemblage A) and GS trophozoites (assemblage B). RESULTS: The polyclonal antibodies generated against WB trophozoites, particularly those recognizing intracellular proteins as well as the proteins present at the plasma membrane (variable-specific surface proteins), showed cross-reactivity with intracellular proteins in GS trophozoites. The use of monoclonal antibodies against beta giardin indicated ventral disc localization, particularly at the periphery in WB trophozoites. Interestingly, although beta giardin was also restricted to the ventral disc in GS trophozoites, the pattern of localization clearly differed in this assemblage. On the other hand, monoclonal antibodies against alpha-1 giardin showed plasma membrane localization in both assemblages with the bare area of GS trophozoites also being distinguished. Moreover, the same localization at the plasma membrane was observed in Portland-1 (Assemblage A) and in P15 (Assemblage E) trophozoites. CONCLUSIONS: We found differences in localization of the beta giardin protein between assemblages A and B, but the same pattern of localization of alpha-1 giardin in strains from Assemblages A, B and E. These findings reinforce the need for more studies based on phenotypic characteristics in order to disclose how far one assemblage is from the other.


Asunto(s)
Proteínas del Citoesqueleto/genética , Regulación de la Expresión Génica , Giardia lamblia/genética , Giardiasis/parasitología , Proteínas Protozoarias/genética , Secuencia de Aminoácidos , Animales , Membrana Celular , Proteínas del Citoesqueleto/química , Proteínas del Citoesqueleto/inmunología , Femenino , Giardia lamblia/clasificación , Giardia lamblia/crecimiento & desarrollo , Giardia lamblia/inmunología , Humanos , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Transporte de Proteínas , Proteínas Protozoarias/química , Proteínas Protozoarias/inmunología , Alineación de Secuencia , Trofozoítos/química , Trofozoítos/crecimiento & desarrollo , Trofozoítos/metabolismo
16.
RNA Biol ; 8(6): 1094-104, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21941123

RESUMEN

Non-coding (nc)RNAs are important players in most biological processes. Although small RNAs such as microRNAs and small interfering RNAs have emerged as exceptionally important regulators of gene expression, great numbers of larger ncRNAs have also been identified. Many of these are abundant and differentially expressed but their functions have in most cases not been elucidated. The social amoeba Dictyostelium discoideum contain the ncRNAs commonly found in eukaryotes. In addition, we previously reported the identification of two novel classes of 42-65 nt long stem-loop forming RNAs, Class I and Class II RNAs, with unknown function. In this study we have further characterized these abundant ncRNAs, which are down regulated during development. We have confirmed expression of 29 Class I RNAs and experimentally verified the formation of the computationally predicted short conserved stem structure. Furthermore, we have for the first time created knockout strains for several small ncRNA genes in D. discoideum and found that deletion of one of the Class I RNAs, DdR-21, results in aberrant development. In addition we have shown that this Class I RNA forms a complex with one or several proteins but do not appear to be associated with ribosomes or polysomes. In a pull down assay, several proteins interacting with DdR-21 were identified, one of these has two RNA recognition motifs (RRMs). The purified RRM containing protein was demonstrated to bind directly and specifically to DdR-21.


Asunto(s)
Dictyostelium/crecimiento & desarrollo , Dictyostelium/genética , ARN no Traducido , Secuencia de Bases , Secuencia Conservada , Ensayo de Cambio de Movilidad Electroforética , Eliminación de Gen , Regulación del Desarrollo de la Expresión Génica , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Fenotipo , Polirribosomas/metabolismo , ARN no Traducido/química , ARN no Traducido/metabolismo , Proteínas de Unión al ARN/metabolismo , Ribosomas/metabolismo
17.
Cell Mol Life Sci ; 67(24): 4249-56, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20593215

RESUMEN

Epstein-Barr virus (EBV) is a human gamma herpes virus that infects B cells and induces their transformation into immortalized lymphoblasts that can grow as cell lines (LCLs) in vitro. EBNA-3 is a member of the EBNA-3-protein family that can regulate transcription of cellular and viral genes. The identification of EBNA-3 cellular partners and a study of its influence on cellular pathways are important for understanding the transforming action of the virus. In this work, we have identified the vitamin D receptor (VDR) protein as a binding partner of EBNA-3. We found that EBNA3 blocks the activation of VDR-dependent genes and protects LCLs against vitamin-D3-induced growth arrest and/or apoptosis. The presented data shed some light on the anti-apoptotic EBV program and the role of the EBNA-3-VDR interaction in the viral strategy.


Asunto(s)
Antígenos Nucleares del Virus de Epstein-Barr/metabolismo , Regulación de la Expresión Génica , Herpesvirus Humano 4/metabolismo , Receptores de Calcitriol/metabolismo , Animales , Calcifediol/metabolismo , Línea Celular , Línea Celular Tumoral , Antígenos Nucleares del Virus de Epstein-Barr/genética , Herpesvirus Humano 4/genética , Humanos , Linfocitos/citología , Linfocitos/fisiología , Espectrometría de Masas , Receptores de Calcitriol/genética
18.
Exp Parasitol ; 127(4): 804-10, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21276445

RESUMEN

The molecular pathogenesis of the intestinal parasite Giardia intestinalis is still not fully understood but excretory-secretory products have been suggested to be important during host-parasite interactions. Here we used SDS-PAGE gels and MALDI-TOF analysis to identify proteins released by Giardia trophozoites during in vitro growth. Serum proteins (mainly bovine serum albumin) in the growth medium, bind to the parasite surface and they are continuously released, which interfere with parasite secretome characterization. However, we identified two released Giardia proteins: elongation factor-1 alpha (EF-1α) and a 58 kDa protein, identified as arginine deiminase (ADI). This is the first description of EF-1α as a released/secreted Giardia protein, whereas ADI has been identified in an earlier secretome study. Two genes encoding EF-1α were detected in the Giardia WB genome 35 kbp apart with almost identical coding sequences but with different promoter and 3' regions. Promoter luciferase-fusions showed that both genes are transcribed in trophozoites. The EF-1α protein localizes to the nuclear region in trophozoites but it relocalizes to the cytoplasm during host-cell interaction. Recombinant EF-1α is recognized by serum from giardiasis patients. Our results suggest that released EF-1α protein can be important during Giardia infections.


Asunto(s)
Giardia lamblia/crecimiento & desarrollo , Factor 1 de Elongación Peptídica/metabolismo , Animales , Western Blotting , Línea Celular Tumoral , Medio de Cultivo Libre de Suero , Electroforesis en Gel de Poliacrilamida , Fibroblastos , Expresión Génica , Giardia lamblia/genética , Giardia lamblia/metabolismo , Giardiasis/sangre , Giardiasis/inmunología , Humanos , Hidrolasas/genética , Hidrolasas/metabolismo , Sueros Inmunes/inmunología , Microscopía Fluorescente , Factor 1 de Elongación Peptídica/genética , Factor 1 de Elongación Peptídica/inmunología , Regiones Promotoras Genéticas , Conejos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Transfección , Trofozoítos/crecimiento & desarrollo , Trofozoítos/metabolismo
19.
Glycobiology ; 20(7): 833-42, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20354005

RESUMEN

Trypanosoma cruzi, the agent of the American trypanosomiasis or Chagas disease, bypasses its lack of de novo synthesis of sialic acids by expressing a surface-anchored trans-sialidase. This enzyme transfers sialic acid residues from the host's sialylglycoconjugates to the parasite's galactosylglycoconjugates. In addition to carrying out a pivotal role in parasite persistence/replication within the infected mammal, the trans-sialidase is shed into the bloodstream and induces alterations in the host immune system by modifying the sialylation of the immune cells. A major obstacle to understand these events is the difficulty to identify the transferred sialic acid among all those naturally occurring on the cell surface. Here, we report the use of azido-modified unnatural sialic acid to identify those molecules that act as cell surface acceptors of the sialyl residue in the trans-sialidase-catalyzed reaction, which might then be involved in the immune alterations induced. In living parasites, we readily observed the transfer of azido-sialic acid to surface mucins. When evaluating mouse thymocytes and splenocytes as acceptors of the azido-sugar, a complex pattern of efficiently tagged glycoproteins was revealed. In both leukocyte populations, the main proteins labeled were identified as different CD45 isoforms. Disruption of the cell architecture increased the number and the molecular weight distribution of azido-sialic acid tagged proteins. Nevertheless, CD45 remained to be the main acceptor. Mass spectrometry assays allowed us to identify other acceptors, mainly integrins. The findings reported here provide a molecular basis to understand the abnormalities induced in the immune system by the trans-sialidase during T. cruzi infection.


Asunto(s)
Glicoproteínas/química , Linfocitos/metabolismo , Neuraminidasa/química , Proteínas Protozoarias/química , Trypanosoma cruzi/enzimología , Trypanosoma cruzi/patogenicidad , Factores de Virulencia/química , Animales , Glicoproteínas/metabolismo , Glicosilación , Interacciones Huésped-Parásitos , Humanos , Células Jurkat , Espectrometría de Masas , Ratones , Ratones Endogámicos C57BL , Neuraminidasa/metabolismo , Proteínas Protozoarias/metabolismo , Trypanosoma cruzi/metabolismo , Factores de Virulencia/metabolismo
20.
IUBMB Life ; 62(11): 833-40, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21117172

RESUMEN

CD44 is a cell surface receptor for hyaluronan which affects cell adhesion and migration, and has been implicated in chronic inflammation and in tumorigenesis. To elucidate the molecular mechanisms underlying its multiple functions, we used a peptide-based pull-down assay to identify proteins that interact with CD44. Nonphosphorylated or phosphorylated peptides from the intracellular CD44 C-terminus, were immobilized and used as baits. Interacting proteins were subjected to SDS-gel electrophoresis and were identified by MALDI-TOF mass spectrometry. Several interaction partners were identified, including proteins involved in cytoskeletal reorganization, transcription, endocytosis, and intracellular transport. An endogenous complex between CD44 and one of the interacting proteins, the actin binding protein IQGAP1, was demonstrated in several normal and transformed cell types.


Asunto(s)
Receptores de Hialuranos/metabolismo , Transducción de Señal/fisiología , Línea Celular , Transformación Celular Neoplásica , Células Cultivadas , Femenino , Humanos , Ácido Hialurónico/metabolismo , Masculino , Unión Proteica , Estructura Terciaria de Proteína/fisiología , Proteómica , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Proteínas Activadoras de ras GTPasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA